Abigail Evans

2.1k total citations
32 papers, 661 citations indexed

About

Abigail Evans is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Abigail Evans has authored 32 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Abigail Evans's work include Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (7 papers) and Advanced Breast Cancer Therapies (6 papers). Abigail Evans is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (7 papers) and Advanced Breast Cancer Therapies (6 papers). Abigail Evans collaborates with scholars based in United Kingdom, France and United States. Abigail Evans's co-authors include Anthony Skene, Mitch Dowsett, Judith M. Bliss, Ian Smith, Maggie Wilcox, Nigel Bundred, Vaughan Keeley, Chris Holcombe, Maggie C.U. Cheang and Katie Riches and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Abigail Evans

29 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abigail Evans United Kingdom	13	414	279	186	161	115	32	661
Véronique Verrièle France	14	400 1.0×	381 1.4×	233 1.3×	296 1.8×	119 1.0×	35	923
Volker Moebus Germany	15	393 0.9×	224 0.8×	97 0.5×	164 1.0×	78 0.7×	52	705
Gennaro Limite Italy	11	392 0.9×	320 1.1×	80 0.4×	146 0.9×	119 1.0×	32	674
Sven‐Börje Ewers Sweden	14	346 0.8×	292 1.0×	255 1.4×	132 0.8×	150 1.3×	27	765
Peter Lim Canada	16	316 0.8×	138 0.5×	145 0.8×	172 1.1×	108 0.9×	32	1.5k
Monika Dufmats Sweden	12	375 0.9×	198 0.7×	231 1.2×	125 0.8×	86 0.7×	13	619
Э. Э. Топузов Russia	9	376 0.9×	241 0.9×	150 0.8×	79 0.5×	123 1.1×	39	583
Justin Poling United States	13	434 1.0×	238 0.9×	152 0.8×	190 1.2×	82 0.7×	22	771
Antonino Iaccarino Italy	18	394 1.0×	333 1.2×	321 1.7×	376 2.3×	97 0.8×	58	1.0k
Tilmann Lantzsch Germany	14	294 0.7×	209 0.7×	101 0.5×	237 1.5×	52 0.5×	26	819

Countries citing papers authored by Abigail Evans

Since Specialization

Citations

This map shows the geographic impact of Abigail Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abigail Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abigail Evans more than expected).

Fields of papers citing papers by Abigail Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abigail Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abigail Evans. The network helps show where Abigail Evans may publish in the future.

Co-authorship network of co-authors of Abigail Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Abigail Evans. A scholar is included among the top collaborators of Abigail Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abigail Evans. Abigail Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bliss, Judith M., Holly Tovey, Abigail Evans, et al.. (2023). Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015). Breast Cancer Research. 25(1). 39–39. 6 indexed citations

Bundred, Nigel, Emma Barrett, Julie Morris, et al.. (2022). Prevention of lymphoedema after axillary clearance by external compression sleeves PLACE randomised trial results. Effects of high BMI. Cancer Medicine. 12(5). 5506–5516. 7 indexed citations

López‐Knowles, Elena, Simone Detre, Margaret Hills, et al.. (2022). Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study. Breast Cancer Research. 24(1). 61–61. 5 indexed citations

Llop‐Guevara, Alba, Alex Pearson, Cristina Cruz, et al.. (2021). 1O Detection of homologous recombination repair deficiency (HRD) in treatment-naive early triple-negative breast cancer (TNBC) by RAD51 foci and comparison with DNA-based tests. Annals of Oncology. 32. S21–S22. 4 indexed citations

Bundred, Nigel, Chris Todd, Julie Morris, et al.. (2020). Increases in arm volume predict lymphoedema and quality of life deficits after axillary surgery: a prospective cohort study. British Journal of Cancer. 123(1). 17–25. 45 indexed citations

Smith, Ian, J.F.R. Robertson, Lucy Kilburn, et al.. (2020). Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial. The Lancet Oncology. 21(11). 1443–1454. 147 indexed citations

Anderton, Jennifer, V. V. Moroz, Perrine Marec‐Bérard, et al.. (2020). International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours – EURO EWING 2012 Protocol. Trials. 21(1). 96–96. 61 indexed citations

Gao, Qiong, Maggie C.U. Cheang, James P. Morden, et al.. (2019). Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients. Breast Cancer Research. 22(1). 2–2. 16 indexed citations

McCabe, Martin G., V. V. Moroz, Maria Khan, et al.. (2019). Results of the first interim assessment of rEECur, an international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma.. Journal of Clinical Oncology. 37(15_suppl). 11007–11007. 29 indexed citations

10.

Dowsett, Mitch, Judith M. Bliss, James P. Morden, et al.. (2018). Abstract GS1-03: Peri-operative aromatase inhibitor treatment in determining or predicting longterm outcome in early breast cancer – The POETIC* Trial (CRUK/07/015). Cancer Research. 78(4_Supplement). GS1–3. 15 indexed citations

11.

Gao, Qiong, Elena López‐Knowles, Maggie C.U. Cheang, et al.. (2018). Major Impact of Sampling Methodology on Gene Expression in Estrogen Receptor–Positive Breast Cancer. JNCI Cancer Spectrum. 2(2). pky005–pky005. 7 indexed citations

12.

Bundred, Nigel, Charlotte Stockton-Powdrell, Vaughan Keeley, et al.. (2015). Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer. Breast Cancer Research and Treatment. 151(1). 121–129. 65 indexed citations

13.

Léary, Alexandra, Abigail Evans, Stephen Johnston, et al.. (2014). Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039). Clinical Cancer Research. 21(13). 2932–2940. 21 indexed citations

14.

Evans, Abigail, Alexandra Léary, Stephen Johnston, et al.. (2012). Abstract LB-222: Lapatinib has antiproliferative effects in both HER2 positive (+) and HER2 negative (-) breast cancer (BC): results from the MAPLE short-term pre-surgical trial (CRUK E/06/039). Cancer Research. 72(8_Supplement). LB–222.

15.

Dowsett, Mitch, I. E. Smith, John Robertson, et al.. (2011). Endocrine Therapy, New Biologicals, and New Study Designs for Presurgical Studies in Breast Cancer. JNCI Monographs. 2011(43). 120–123. 53 indexed citations

16.

Evans, Abigail, Sunil Pancholi, Ian Farmer, et al.. (2010). EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapy. British Journal of Cancer. 102(8). 1235–1243. 18 indexed citations

17.

Iuliano-Burns, Sandra, et al.. (2003). Does calcium from milk minerals enhance bone mass accrual and alter bone dimensions during growth better than calcium carbonate.. Journal of Bone and Mineral Research. 18. 1 indexed citations

18.

Sullivan, Alexandra, Martin Yuille, Claire E. Repellin, et al.. (2002). Concomitant inactivation of p53 and Chk2 in breast cancer. Oncogene. 21(9). 1316–1324. 67 indexed citations

19.

O’Nions, Jenny, L. Brooks, Alice Sullivan, et al.. (2001). p73 is over-expressed in vulval cancer principally as the Δ2 isoform. British Journal of Cancer. 85(10). 1551–1556. 46 indexed citations

20.

Evans, Abigail, et al.. (1999). Comparison of two new methods for the measurement of lung volumes with two standard methods. Thorax. 54(4). 329–333. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact